The amino-terminal domain of the CCR2 chemokine receptor acts as coreceptor for HIV-1 infection

Journal of Clinical Investigation

Volumn 100, Issue 3, 1997, Pages 497-502

  Frade, José M R ^a   Llorente, Mercedes ^a   Mellado, Mario ^a   Alcamí, José ^b   Gutiérrez Ramos, José C ^a   Zaballos, Angel ^a   Del Real, Gustavo ^a   Martínez A , Carlos ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Chemokine receptor; HIV 1 coreceptor; Monoclonal antibodies

Indexed keywords

CHEMOKINE RECEPTOR; MONOCLONAL ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 0030762561     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119558     Document Type: Article

References (35)

1. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55:97-179.
2. Schall, T.J. 1994. The chemokines. In The Cytokine Handbook, 2nd ed. Academic Press, NY. 181-272.
3. Schall, T.J., and K.B. Bacon. 1994. Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6:865-873.
4. Horuk, R. 1994. Molecular properties of the chemokine receptor family. TIPS (Trends Pharmacol. Sci.). 15:159-165.
5. Murphy, P.M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593-633.
6. 8+ T cells. Science (Wash. DC). 270: 1811-1815.
7. Alkhatib, G., C. Combadiere, C.C. Broder, Y. Feng, P.E. Kennedy, P.M. Murphy, and E.A. Berger. 1996. CC CKR5: A RANTES. MIP-1α. MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (Wash. DC). 272:1955-1958.
8. Dragic, T., V. Litwin, G.P. Allaway, S.R. Martin, Y. Huang, K.A. Nagashima, C. Cayanan, P.J. Maddon, R.A. Koup, J.P. Moore, and W.A. Paxton. 1996. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (Lond.). 381:667-673.
9. Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R.E. Sutton, C.M. Hill, et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature (Lond.). 381:661-666.
10. Doranz, B.J., J. Rucker, Y. Yi, R.J. Smyth, M. Samson, S.C. Peiper, M. Parmentier, R.C. Collman, and R.W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the bβchemokine receptors CKR-5, CKR-3, and CKR-2β as fusion cofactors. Cell. 85:1149-1158.
11. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P.D. Ponath, L. Wu, C.R. Mackay, G. LaRosa, W. Newman, et al. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1135-1148.
12. Samson, M., F. Libert, B.J. Doranz, J. Rucker, C. Liesnard, C.-M. Farber, S. Saragosti, C. Lapouméroulie, J. Cognaux, C. Forceille, et al. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (Lond.). 382:722-725.
13. Feng, Y., C.C. Broder, P.E. Kennedy, and E.A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (Wash. DC). 272:872-877.
14. Bleuel, C.C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T.A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (Lond.). 382:829-833.
15. Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J.-L. Virelizier, F. Arenzana-Seisdedos, O. Schwartz, J.-M. Heard, I. Clark-Lewis, D.F. Legler, et al. 1996. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (Lond.). 382:833-835.
16. Van Damme, J., P. Proost, W. Put, S. Arens, J.P. Lenaerts, R. Conings, G. Opdenakker, H. Heremans, and A. Billiau. 1994. Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J. Immunol. 152:5495-5502.
17. Laning, J., H. Kawasaki, E. Tanaka, Y. Luo, and M. Dorf. 1994. Inhibition of in vivo tumor growth by the beta chemokine, TCA3. J. Immunol. 153: 4625-4635.
18. Van Riper, G., S. Siciliano, P.A. Fischer, R. Meurer, M.S. Springer, and H. Rosen. 1993. Characterization and species distribution of high affinity GTP-coupled receptors for human RANTES and monocyte chemoattractant protein-1. J. Exp. Med. 177:851-856.
19. Charo, I.F., S.J. Myers, A. Herman, C. Franci, A.J. Connolly, and S.R. Coughlin. 1994. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc. Natl Acad. Sci. USA. 91:2752-2756.
20. Carr, M.W., S.J. Roth, E. Luther, S.S. Rose, and T.A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA. 91:3652-3656.
21. Loetscher, M., B. Gerber, P. Loetscher, S.A. Jones, L. Piali, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:963-969.
22. Adachi, A., H.E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M.A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with infectious molecular clone. J. Virol. 59:284-291.
23. Burton, D.R., J. Pyati, R. Koduri, S.J. Sharp, G.B. Thornton, P.W.H.I. Pareen, L.S.W. Sawyer, R.M. Hendry, N. Dunlop, P.L. Nara, et al. 1994. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science (Wash. DC). 266:1024-1027.
24. Gayle, R.B., III, P.R. Sleath, S. Srinivason, C.W. Birks, K.S. Weerawarna, D.P. Cerretti, C.J. Kozlosky, N. Nelson, T. Vanden Bos, and M.P. Beckman. 1993. Importance of the amino terminus of the interleukin-8 receptor in ligand interactions. J. Biol. Chem. 268:7283-7289.
25. Liu, R., W.A. Paxton, S. Choe, D. Ceradini, S.R. Martin, R. Horuk, M.E. MacDonald, H. Stuhlmann, R.A. Koup, and N.R. Landau. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-377.
26. Howard, O.M., A. Ben-Baruch, and J.J. Oppenheim. 1996. Chemokines: progress toward identifying molecular targets for therapeutic agents. Trends Biotechnol. 14:46-51.
27. Bokoch, G.M. 1995. Chemoattractant signaling and leukocyte activation. Blood. 86:1649-1660.
28. Hebert, C.A., A. Chuntharapai, M. Smith, T. Colby, J. Kim, and R. Horuk. 1993. Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain. J. Biol. Chem. 268:18549-18553. [published erratum appears in J. Biol. Chem. 1994. 269:16520].
29. Arenzana-Seisdedos, F., J.-L. Virelizier, D. Rousset, I. Clark-Lewis, P. Loetscher, B. Moser, and M. Baggiolini. 1996. HIV blocked by chemokine antagonist. Nature (Lond.). 383:400.
30. Rucker, J., M. Samson. B.J. Doranz, F. Libert, J.F. Berson, Y. Yi, R.J. Smyth, R.G. Collman, C.C. Broder, G. Vassart, et al. 1996. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell. 87:437-446.
31. Atchison, R.E., J. Gosling, F.S. Monteclaro, C. Franci, L. Digilio, I.F. Charo, and M.A. Goldsmith. 1996. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science (Wash. DC). 274:1924-1926.
32. Dean, M., M. Carrington, C. Winkler, G.A. Huttley, M.W. Smith, R. Allikments, J.J. Goedert, S.P. Buchbinder, E. Vittinghoff, E. Gomperts, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science (Wash. DC). 273:1856-1862.
33. Huang, Y., W.A. Paxton, S.M. Wolinsky, A.U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbaksh, et al. 1996. The role of mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 2: 1240-1243.
34. Nieto, M., J.M.R. Frade, D. Sancho, M. Mellado, C. Martinez-A., and F. Sánchez-Madrid. 1997. Polarization of chemokine receptors to the leading edge during lymphocyte chemotaxis. J. Exp. Med. 186:1-6.
35. Dittmar, M.T., A. McKnight, G. Simmons, P.R. Clapham, R.A. Weiss, and P. Simmonds. 1997. HIV-1 tropism and co-receptor use. Nature (Lond.). 385:495-496.